BENTSUR RON 4
4 · Nuvectis Pharma, Inc. · Filed May 15, 2024
Insider Transaction Report
Form 4
BENTSUR RON
DirectorChairman & CEO10% Owner
Transactions
- Purchase
Common Stock
2024-05-14$6.74/sh+1,940$13,076→ 3,246,424 total
Footnotes (2)
- [F1]Reflects the weighted average purchase price. The range of prices for the shares purchased was $6.65 to $6.94. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price
- [F2]Includes 426,759 shares of restricted stock.